Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination

BACKGROUND: The availability of human papillomavirus (HPV) DNA testing and vaccination against HPV types 16 and 18 (HPV-16,18) motivates questions about the cost-effectiveness of cervical cancer prevention in the United States for unvaccinated older women and for girls eligible for vaccination. METH...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Goldhaber-Fiebert, Jeremy D., Stout, Natasha K., Salomon, Joshua A., Kuntz, Karen M., Goldie, Sue J.
Format: Artigo
Jezik:Inglês
Izdano: 2008
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3099548/
https://ncbi.nlm.nih.gov/pubmed/18314477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djn019
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki